High-Protein Nutrition for Heart Failure-related Muscle Wasting
(ASTRID-HF Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing whether protein supplements can help patients with heart failure who are losing muscle. The study will compare different amounts of protein to see if it helps build muscle in these patients. Researchers believe that extra protein might counteract the body's muscle-wasting processes.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you must be on guideline-directed medical therapy unless it's contraindicated or not tolerated.
What data supports the idea that High-Protein Nutrition for Heart Failure-related Muscle Wasting is an effective treatment?
The available research shows that high-protein nutrition can be effective for heart failure-related muscle wasting. In a study with patients suffering from chronic heart failure and cachexia, those who received a high-protein supplement gained weight and improved their quality of life. Specifically, 19 out of 20 patients gained weight after 6 weeks, and 17 out of 19 maintained this gain after 18 weeks. Additionally, there was a significant improvement in their quality of life. This suggests that high-protein nutrition can help improve body weight and overall well-being in these patients.12345
What safety data exists for high-protein nutrition in treating muscle wasting in heart failure?
The research indicates that high-protein nutrition, particularly with leucine-enriched supplements, is generally safe and beneficial for older adults experiencing muscle wasting. Whey protein-enriched supplements are commonly used in clinical settings to preserve lean body mass. Studies suggest that increasing dietary protein intake above the current RDA may help maintain muscle mass in older individuals without adverse effects on renal function. However, long-term studies are needed to confirm the safety and efficacy of these supplements.14678
Is Ensure Max Protein a promising treatment for muscle wasting in heart failure patients?
Research Team
Eligibility Criteria
This trial is for adults aged 18-100 with heart failure and reduced ejection fraction (HFrEF), experiencing muscle wasting. They must be on standard heart failure treatments, have a left ventricular ejection fraction ≤40%, and show signs of severe heart failure like hospitalizations or significant weight loss. Excluded are pregnant women, those with certain muscle disorders, severe kidney issues, allergies to milk/protein/lactose intolerance/galactosemia, or very high body weight/BMI.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dietary protein supplementation with Ensure products, randomized between no, low, or high-dose groups
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Ensure Max Protein (Protein Supplementation)
- Ensure Original (Protein Supplementation)
Ensure Max Protein is already approved in Canada for the following indications:
- Nutritional supplement for patients with malnutrition, including those with heart failure
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tufts Medical Center
Lead Sponsor
Michael Dandorph
Tufts Medical Center
Chief Executive Officer since 2022
MBA
Helen Boucher
Tufts Medical Center
Chief Medical Officer since 2022
MD, FACP, FIDSA
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Dr. Gary H. Gibbons
National Heart, Lung, and Blood Institute (NHLBI)
Chief Executive Officer since 2012
MD from Harvard Medical School
Dr. James P. Kiley
National Heart, Lung, and Blood Institute (NHLBI)
Chief Medical Officer since 2011
MD from University of California, San Francisco